Alzheimer's Drug Discovery Foundation

Alzheimer's Drug Discovery Foundation

Alzheimer's Drug Discovery Foundation

Overview
Date Founded

2004

Headquarters

57 WEST 57TH ST, NEW YORK, NY, 10019

Charitable Causes

Alzheimer's Disease
Social Science Research

Employees (Worldwide)

11 - 50

Industries

Biotechnology

Company Description

The Alzheimer’s Drug Discovery Foundation was established in 2004 as a public charity to support the advancement of drugs to prevent, treat, and cure Alzheimer’s disease, related dementias, and cognitive aging. This strategy of venture philanthropy is based on the idea that research grant recipients are engaged in projects that are potentially viable in the marketplace with a possible return on investment.

Executives & Employees

Chief Executive Officer

Assistant Secretary & Treasurer

Executive Director & Chief Operating Officer

Treasurer

Treasurer

Co-Founder

Co-Founder

Vice Chairman, Board of Governors

Founding Executive Director & Chief Science Officer

Chief of Staff

Board of Directors
Paths to Alzheimer's Drug Discovery Foundation
Potential Connections via
Relationship Science
You
Alzheimer's Drug Discovery Foundation
Key Stats and Financials As of 2017
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$14.5M
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Investments
Details Hidden

Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA.

Details Hidden

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company was founded by Leen Kawas and Joseph Harding in 2011 and is headquartered in Seattle, WA.

Details Hidden

Tetra Therapeutics engages in the development of therapeutic products for neurological disorders. The firm offers BPN14770 PDE4D Inhibitor and PDE4B Inhibitor products. The company was founded by Mark E. Gurney in 2011 and is headquartered in Grand Rapids, MI.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alzheimer's Drug Discovery Foundation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alzheimer's Drug Discovery Foundation's profile does not indicate a business or promotional relationship of any kind between RelSci and Alzheimer's Drug Discovery Foundation.